← Back to Search

Flavonoids

Elderberry for Coronavirus

N/A
Recruiting
Research Sponsored by Franklin Health Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 13 weeks
Awards & highlights

Study Summary

This trial will test how well ElderCraft® elderberry extract affects immunity.

Eligible Conditions
  • Coronavirus
  • Common Cold
  • Influenza
  • Flu
  • Cold

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~13 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 13 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Duration of Upper Respiratory Events
Incidence of Upper Respiratory Events
Incidence of Upper Respiratory Symptomatic Days
+1 more
Secondary outcome measures
Cognitive Wellbeing
Duration of COVID-19
Duration of influenza
+7 more
Other outcome measures
Adverse Events
Digestive Health

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intervention ArmExperimental Treatment1 Intervention
Participants will receive a 13-week supply of ElderCraft® (European black elderberry extract standardized to 15% anthocyanins). Each capsule contains 300mg of extract; participants will take a total of two capsules each day.
Group II: Placebo ArmPlacebo Group1 Intervention
Participants will receive a 13-week supply of inert placebo capsules matched for polysaccharide content. Participants will take a total of two capsules each day.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Elderberry
2011
N/A
~80

Find a Location

Who is running the clinical trial?

IPRONAUNKNOWN
Franklin Health ResearchLead Sponsor
15 Previous Clinical Trials
3,036 Total Patients Enrolled
Artemis InternationalUNKNOWN
1 Previous Clinical Trials
57 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participant recruitment open for this experiment?

"This medical experiment is presently recruiting patients, as evidenced by the clinicaltrials.gov listing for this project which was first released on August 26th 2022 and has seen recent alterations on October 10th of the same year."

Answered by AI

What is the aggregate population of this medical experiment?

"Affirmative. The clinicaltrials.gov website indicates that the research is presently recruiting patients and was first made available on August 26th 2022 with a more recent edit on October 10th 2022. 420 individuals are sought for this trial at one medical centre."

Answered by AI

Is this research trial open to those over the age of 45?

"This clinical trial is exclusively for patients aged between 20 and 65. However, there are 180 trials available to those under 18 years of age as well as 952 studies open to people over the senior citizen mark."

Answered by AI

Could I qualify to participate in this medical research project?

"This clinical research is recruiting participants aged 20-65 with Covid-19. Eligibility criteria include the ability to take oral supplements and a commitment to taking 2 capsules daily for 3 months, employment in an occupation with direct contact with the public or regular engagement in activities of high exposure, agreement to adhere to certain lifestyle considerations during the study period, signed informed consent form, willingness and demonstrated capacity to follow all procedures of the trial as well as availability for its duration, BMI under 31 (if female), and use of highly effective contraception prior to screening."

Answered by AI

What positive developments are anticipated from this experiment?

"This 13-week medical experiment will measure the frequency of upper respiratory symptoms, whilst also tracking stress levels via The Franklin Stress Scale. Additionally, it will count confirmed influenza diagnoses and their duration to determine an event's length."

Answered by AI
~163 spots leftby Mar 2025